Maternal blood lead levels and the risk of pregnancy-induced hypertension: The EDEN cohort study

Environmental Health Perspectives

Volumn 117, Issue 10, 2009, Pages 1526-1530

  Yazbeck, Chadi ^a,b,c   Thiebaugeorges, Olivier ^d   Moreau, Thierry ^a,b   Goua, Valérie ^e   Debotte, Ginette ^a,b   Sahuquillo, Josiane ^a,b   Forhan, Anne ^a,b   Foliguet, Bernard ^d   Magnin, Guillaume ^e   Slama, Rémy ^f   Charles, Marie Aline ^a,b   Huel, Guy ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f UNIV GRENOBLE ALPES   (France)

Author keywords

Cadmium; Environmental health; Epidemiology; Gestation; Hypertension; Lead; Manganese

Indexed keywords

CALCIUM; LEAD;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FRANCE; GESTATION PERIOD; HUMAN; INCIDENCE; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MATERNAL HYPERTENSION; PARITY; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; WEIGHT GAIN;

ADULT; BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LEAD; MIDDLE AGED; PREGNANCY; RISK FACTORS; SPECTROPHOTOMETRY, ATOMIC; YOUNG ADULT;

EID: 70449589837     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800488     Document Type: Article

References (44)

1. Aardenburg R, Spaanderman ME, Courtar DA, van Eijndhoven HW, de Leeuw PW, Peeters LL. 2005. A subnormal plasma volume in formerly preeclamptic women is associated with a low venous capacitance. J Soc Gynecol Investig 12:107-111. (Pubitemid 40202845)
2. Anastasakis E, Papantoniou N, Daskalakis G, Mesogitis S, Antsaklis A. 2008. Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow. J Obstet Gynaecol 28:285-289. (Pubitemid 351873795)
3. Angell NF, Lavery JP. 1982. The relationship of blood lead levels to obstetric outcome. Am J Obstet Gynecol 142:40-46. (Pubitemid 12209591)
4. Ayala DE, Hermida RC. 2001. Influence of parity and age on ambulatory monitored blood pressure during pregnancy. Hypertension 38:753-758.
5. Batuman V, Landy E, Maesaka JK, Wedeen RP. 1983. Contribution of lead to hypertension with renal impairment. N Engl J Med 309:17-21.
6. Bonithon-Kopp C, Huel G, Grasmick C, Sarmini H, Moreau T. 1986. Effects of pregnancy on the inter-individual variations in blood levels of lead, cadmium and mercury. Biol Res Pregnancy Perinatol 7:37-42. (Pubitemid 16164868)
7. Campagna D, Huel G, Girard F, Sahuquillo J, Blot P. 1999. Environmental lead exposure and activity of delta-aminolevulinic acid dehydratase (ALA-D) in maternal and cord blood. Toxicology 134:143-152. (Pubitemid 29248887)
8. Campagna D, Huel G, Hellier G, Girard F, Sahuquillo J, Fagot-Campagna A, et al. 2000. Negative relationships between erythrocyte Ca-pump activity and lead levels in mothers and newborns. Life Sci 68:203-215.
9. Carmignani M, Volpe AR, Boscolo P, Qiao N, Di Gioacchino M, Grilli A, et al. 2000. Catcholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment. Life Sci 68:401-415. (Pubitemid 32011893)
10. Dawson EB, Evans DR, Kelly R, Van Hook JW. 2000. Blood cell lead, calcium, and magnesium levels associated with pregnancy-induced hypertension and preeclampsia. Biol Trace Elem Res 74:107-116. (Pubitemid 30367208)
11. Dawson EB, Evans DR, Nosovitch J. 1999. Third-trimester am niotic fluid metal levels associated with preeclampsia. Arch Environ Health 54:412-415. (Pubitemid 30013670)
12. Drouillet P, Forhan A, De Lauzon-Guillain B, Thiebaugeorges O, Goua V, Magnin G, et al. 2009. Maternal fatty acid intake and fetal growth: evidence for an association in overweight women. The "EDEN mother-child" cohort (study of pre- and early postnatal determinants of the child's development and health). Br J Nutr 101(4):583-591.
13. Fréry N, Girard F, Moreau T, Blot P, Sahuquillo J, Hajem S, et al. 1993. Validity of hair cadmium in detecting chronic cadmium exposure in general populations. Bull Environ Contam Toxicol 50:736-743. (Pubitemid 23129257)
14. Goldstein JD, Garry DJ, Maulik D. 2000. Obstetric conditions and erythropoietin levels. Am J Obstet Gynecol 182:1055-1057.
15. Gonick HC, Behari JR. 2002. Is lead exposure the principal cause of essential hypertension? Med Hypotheses 59:239-246.
16. Gonick HC, Ding Y, Bondy SC, Ni Z, Vaziri ND. 1997. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492. (Pubitemid 27528093)
17. Groom KM, North RA, Poppe KK, Sadler L, McCowan LM. 2007. The association between customised small for gestational age infants and pre-eclampsia or gestational hypertension varies with gestation at delivery. BJOG 114:478-484. (Pubitemid 46393307)
18. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ, Korsch MJ, Vimpani G. 1997. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med 130:51-62. (Pubitemid 27340788)
19. Hertz-Picciotto I, Croft J. 1993. Review of the relation between blood lead and blood pressure. Epidemiol Rev 15:352-373. (Pubitemid 24072634)
20. Hertz-Picciotto I, Schramm M, Watt-Morse M, Chantala K, Anderson J, Osterloh J. 2000. Patterns and determinants of blood lead during pregnancy. Am J Epidemiol 152:829-837. (Pubitemid 30822647)
21. Hrazdilova O, Unzeitig V, Znojil V, Izakovicova-Holla L, Janku P, Vasku A. 2001. Relationship of age and the body mass index to selected hypertensive complications in pregnancy. Int J Gynaecol Obstet 75:165-169. (Pubitemid 33010765)
22. Huel G, Boudène C, Jouan M, Lazar P. 1986. Assessment of exposure to lead of the general population in the French community through biological monitoring. Int Arch Occup Environ Health 58:131-139. (Pubitemid 16097040)
23. Huel G, Campagna D, Girard F, Moreau T, Blot P. 2000. Does selenium reduce the risk of threatened preterm delivery associated with placental cytochrome P450-1A1 activity? Environ Res 84:228-233.
24. Kosanovic M, Jokanovic M, Jevremovic M, Dobric S, Bokonjic D. 2002. Maternal and fetal cadmium and selenium status in normotensive and hypertensive pregnancy. Biol Trace Elem Res 89:97-103. (Pubitemid 35283701)
25. Lee AM, Huel G, Godin J, Hellier G, Sahuquillo J, Moreau T, et al. 1995. Inter-individual variation of selenium in maternal plasma, cord plasma and placenta. Sci Total Environ 159:119-127.
26. Mergler D, Huel G, Bellanger S, Bowler R, Truchon G, Ostiguy C, et al. 1996. Surveillance of early neurotoxic dysfunction. Neurotoxicology 17:803-812.
27. Moreau T, Hannaert P, Orssaud G, Huel G, Garay RP, Claude JR, et al. 1988. Influence of membrane sodium transport upon the relation between blood lead and blood pressure in a general male population. Environ Health Perspect 78:47-51. (Pubitemid 18188348)
28. National High Blood Pressure Education Program. 2000. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183:S1-S22.
29. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. 2007. Lead exposure and cardiovascular disease - a systematic review. Environ Health Perspect 115:472-482. (Pubitemid 46554449)
30. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. 2002. An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 16:123-131. (Pubitemid 34182922)
31. O'Flaherty E, Polak J, Andriot M. 1995. Incorporation of temporal factors into physiologically based kinetic models for risk assessment. Inhal Toxicol 7:917-925.
32. Rabinowitz M, Bellinger D, Leviton A, Needleman H, Schoenbaum S. 1987. Pregnancy hypertension, blood pressure during labor, and blood lead levels. Hypertension 10:447-451. (Pubitemid 17160046)
33. Rayman MP, Bode P, Redman CW. 2003. Low selenium status is associated with the occurrence of the pregnancy disease preeclampsia in women from the United Kingdom. Am J Obstet Gynecol 189:1343-1349. (Pubitemid 37542170)
34. Rothenberg SJ, Manalo M, Jiang J, Khan F, Cuellar R, Reyes S, et al. 1999. Maternal blood lead level during pregnancy in South Central Los Angeles. Arch Environ Health 54:151-157. (Pubitemid 29297438)
35. Schwartz J. 1995. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health 50:31-37.
36. Sowers M, Jannausch M, Scholl T, Li W, Kemp FW, Bogden JD. 2002. Blood lead concentrations and pregnancy outcomes. Arch Environ Health 57:489-495. (Pubitemid 36278193)
37. Telisman S, Pizent A, Jurasovic J, Cvitkovic P. 2004. Lead effect on blood pressure in moderately lead-exposed male workers. Am J Ind Med 45:446-454. (Pubitemid 38586081)
38. U.S. Environmental Protection Agency. 2006. Air Quality Criteria for Lead (Final). Available: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=158823 [accessed 6 November 2008].
39. Vaziri ND, Khan M. 2007. Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension. Clin Exp Pharmacol Physiol 34:920-925. (Pubitemid 47083964)
40. Vaziri ND, Sica DA. 2004. Lead-induced hypertension: role of oxidative stress. Curr Hypertens Rep 6:314-320. (Pubitemid 39144657)
41. Verity MA. 1999. Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology 20:489-497.
42. Vigeh M, Yokoyama K, Mazaheri M, Beheshti S, Ghazizadeh S, Sakai T, et al. 2004. Relationship between increased blood lead and pregnancy hypertension in women without occupational lead exposure in Tehran, Iran. Arch Environ Health 59:70-75. (Pubitemid 41060162)
43. Vigeh M, Yokoyama K, Ramezanzadeh F, Dahaghin M, Fakhriazad E, Seyedaghamiri Z, et al. 2008. Blood manganese concentrations and intrauterine growth restriction. Reprod Toxicol 25:219-223.
44. Vigeh M, Yokoyama K, Ramezanzadeh F, Dahaghin M, Sakai T, Morita Y, et al. 2006. Lead and other trace metals in preeclampsia: a case-control study in Tehran, Iran. Environ Res 100:268-275. (Pubitemid 43155279)